Should Caffeine Be Avoided Following Free Flaps: Fact or Fiction?

Abstract

Background

Many microsurgeons recommend that their patients avoid all compounds containing caffeine after free tissue transfer, however, there is little in the literature to implicate caffeine as a contributor to flap loss. While caffeine has historically been viewed as a vasoconstrictor that could theoretically impair flap perfusion, its physiological effects are complex, involving both vasoconstrictive and vasodilatory mechanisms. This review aims to determine whether caffeine consumption may increase flap-related complications including ultimate failure.

Methods

A narrative review was conducted through PubMed and Google Scholar to evaluate the mechanism of action of caffeine. Articles were included if they provided insights into caffeine's mechanisms of action in the central nervous system, cardiovascular system, endothelium, and microcirculation.

Results

Caffeine causes the release of neurotransmitters in the CNS promoting wakefulness through the antagonism of adenosine receptors. In both smooth muscle and vascular endothelium, caffeine promotes vasodilation through the activation or inhibition of different types of receptors including adenosine, inositol triphosphate, and nitrous oxide. Studies in both human and animal models suggest that caffeine does not significantly affect microvascular perfusion or anastomotic patency. Data suggest that habitual caffeine consumers show blunted vascular responses, further mitigating concerns in flap outcomes.

Conclusion

Despite current recommendations for caffeine restriction following free tissue transfer, the existing evidence does not support caffeine as a major risk factor for flap failure. Postoperative caffeine avoidance may be unnecessary, particularly for habitual users. Larger prospective studies are needed to further elucidate caffeine's role in microsurgical outcomes and to explore the effects of other stimulants, such as ADHD medications, on microvascular circulation.

Keywords

caffeine - microsurgery - free flap

Publikationsverlauf

Eingereicht: 19. Dezember 2024

Angenommen: 24. April 2025

Artikel online veröffentlicht:
15. Mai 2025

• References

• 1 Frary CD, Johnson RK, Wang MQ. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 2005; 105 (01) 110-113
• 2 Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev 2014; 2019 (05) CD009281
• 3 Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ. Beverage caffeine intakes in the U.S. Food Chem Toxicol 2014; 63: 136-142
• 4 Addicott MA. Caffeine use disorder: a review of the evidence and future implications. Curr Addict Rep 2014; 1 (03) 186-192
• 5 Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012; 366 (20) 1891-1904
• 6 Chen KT, Mardini S, Chuang DCC. et al. Timing of presentation of the first signs of vascular compromise dictates the salvage outcome of free flap transfers. Plast Reconstr Surg 2007; 120 (01) 187-195
• 7 Pattani KM, Byrne P, Boahene K, Richmon J. What makes a good flap go bad? A critical analysis of the literature of intraoperative factors related to free flap failure. Laryngoscope 2010; 120 (04) 717-723
• 8 Shen AY, Lonie S, Lim K, Farthing H, Hunter-Smith DJ, Rozen WM. Free flap monitoring, salvage, and failure timing: a systematic review. J Reconstr Microsurg 2021; 37 (03) 300-308
• 9 Chang EI, Chang EI, Soto-Miranda MA. et al. Comprehensive evaluation of risk factors and management of impending flap loss in 2138 breast free flaps. Ann Plast Surg 2016; 77 (01) 67-71
• 10 Hernandez Alvarez A, Lee D, Kim EJ. et al. An institutional analysis of early postoperative free tissue transfer takeback procedures. J Reconstr Microsurg 2025; 41 (02) 170-176
• 11 Dinman S, Giovannone MK. The care and feeding of microvascular flaps: how nurses can help prevent flap loss. Plast Surg Nurs 1994; 14 (03) 154-164
• 12 Grant DM, Tang BK, Kalow W. Variability in caffeine metabolism. Clin Pharmacol Ther 1983; 33 (05) 591-602
• 13 Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 1995; 92 (08) 2135-2141
• 14 Umemura T, Ueda K, Nishioka K. et al. Effects of acute administration of caffeine on vascular function. Am J Cardiol 2006; 98 (11) 1538-1541
• 15 Londos C, Wolff J. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci U S A 1977; 74 (12) 5482-5486
• 16 van Calker D, Biber K, Domschke K, Serchov T. The role of adenosine receptors in mood and anxiety disorders. J Neurochem 2019; 151 (01) 11-27
• 17 Degubareff T, Sleator Jr W. Effects of caffeine on mammalian atrial muscle, and its interaction with adenosine and calcium. J Pharmacol Exp Ther 1965; 148: 202-214
• 18 Clark A, Olson CB. Effects of caffeine and isoprenaline on mammalian ventricular muscle. Br J Pharmacol 1973; 47 (01) 1-11
• 19 Brozovich FV, Nicholson CJ, Degen CV, Gao YZ, Aggarwal M, Morgan KG. Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders. Pharmacol Rev 2016; 68 (02) 476-532
• 20 Sofi F, Conti AA, Gori AM. et al. Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr Metab Cardiovasc Dis 2007; 17 (03) 209-223
• 21 Watanabe C, Yamamoto H, Hirano K, Kobayashi S, Kanaide H. Mechanisms of caffeine-induced contraction and relaxation of rat aortic smooth muscle. J Physiol 1992; 456 (01) 193-213
• 22 Ozaki H, Ohyama T, Sato K, Karaki H. Ca²(⁺)-dependent and independent mechanisms of sustained contraction in vascular smooth muscle of rat aorta. Jpn J Pharmacol 1990; 52 (03) 509-512
• 23 Sato K, Ozaki H, Karaki H. Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2. J Pharmacol Exp Ther 1988; 246 (01) 294-300
• 24 Echeverri D, Montes FR, Cabrera M, Galán A, Prieto A. Corrigendum to “caffeine's vascular mechanisms of action”. Int J Vasc Med 2019; 2019: 7480780
• 25 Surks HK, Mochizuki N, Kasai Y. et al. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science 1999; 286 (5444) 1583-1587
• 26 Guerrero A, Singer JJ, Fay FS. Simultaneous measurement of Ca²⁺ release and influx into smooth muscle cells in response to caffeine. A novel approach for calculating the fraction of current carried by calcium. J Gen Physiol 1994; 104 (02) 395-422
• 27 Shaughness G, McKittrick J, Akelina Y, Strauch RJ. Caffeine does not reduce blood flow following arterial anastomosis in the rat. J Reconstr Microsurg 2016; 32 (09) 657-660
• 28 Sakarya AH, Uzun H, Türkkanı A. et al. Effects of systemic and local caffeine on vessel diameter, anastomosis patency, and intimal hyperplasia in the rat. J Reconstr Microsurg 2019; 35 (04) 244-253
• 29 Knight R, Pagkalos J, Timmons C, Jose R. Caffeine consumption does not have an effect on digital microvascular perfusion assessed by laser Doppler imaging on healthy volunteers: a pilot study. J Hand Surg Eur Vol 2015; 40 (04) 412-415
• 30 Barton B, Kleinert JM. The effect of caffeine on digital haemodynamics. J Hand Surg [Br] 1994; 19 (03) 301-302
• 31 Kotha V, Lakhiani C, Lee DW, Fan KL, Song DH. Coffee and free flaps: foes no more. Plast Reconstr Surg 2019; 144 (02) 338e-340e
• 32 Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D. Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res 1987; 61 (06) 779-786
• 33 Robertson D, Frölich JC, Carr RK. et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 1978; 298 (04) 181-186
• 34 Casiglia E, Bongiovì S, Paleari CD. et al. Haemodynamic effects of coffee and caffeine in normal volunteers: a placebo-controlled clinical study. J Intern Med 1991; 229 (06) 501-504
• 35 Shaughness G, Akelina Y, Strauch RJ. Dietary guidelines for caffeine and chocolate after digital replantation. J Hand Surg Am 2015; 40 (04) 810-812
• 36 Phillips-Bute BG, Lane JD. Caffeine withdrawal symptoms following brief caffeine deprivation. Physiol Behav 1997; 63 (01) 35-39
• 37 Burkhard JP, Wepfer A, Löffel LM, Bachmann KF, Wuethrich PY. The role of intraoperative and early postoperative blood pressure variations, fluid balance and inotropics in fibula free flap head and neck reconstruction: a retrospective analysis. J Clin Med 2023; 12 (24) 7753
• 38 Franco R, Oñatibia-Astibia A, Martínez-Pinilla E. Health benefits of methylxanthines in cacao and chocolate. Nutrients 2013; 5 (10) 4159-4173
• 39 Loy BD, O'Connor PJ, Lindheimer JB, Covert SF. Caffeine is ergogenic for adenosine A_2A receptor gene (ADORA2A) T allele homozygotes: a pilot study. J Caffeine Res 2015; 5 (02) 73-81
• 40 Svenningsson P, Nomikos GG, Fredholm BB. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci 1999; 19 (10) 4011-4022
• 41 Torres-Acosta N, O'Keefe JH, O'Keefe CL, Lavie CJ. Cardiovascular effects of ADHD therapies: JACC review topic of the week. J Am Coll Cardiol 2020; 76 (07) 858-866
• 42 Tan G, Mintz AJ, Mintz B. et al. Peripheral vascular manifestation in patients receiving an amphetamine analog: a case series. Vasc Med 2019; 24 (01) 50-55